Featured Research

from universities, journals, and other organizations

Macrophages, Not Stem Cells, Correct Liver Disease By Fusion

Date:
July 12, 2004
Source:
Oregon Health & Science University
Summary:
An Oregon Health & Science University study is defying a long-accepted assertion among many scientists that stem cells repair diseased tissue by transforming into other cell types in a process called plasticity.

PORTLAND, Ore. -- An Oregon Health & Science University study is defying a long-accepted assertion among many scientists that stem cells repair diseased tissue by transforming into other cell types in a process called plasticity.

The first study from OHSU's new Oregon Stem Cell Center, published in the current issue of the journal Nature Medicine, found that mature macrophages derived from bone marrow stem cells, and not bone marrow stem cells themselves, are what fuse with diseased liver cells, ultimately curing a genetic liver disease.

"The most important discovery is you don't need to transplant stem cells at all," said study co-author Markus Grompe, M.D., professor of molecular and medical genetics, and pediatrics, OHSU School of Medicine, and director of the Oregon Stem Cell Center. "If you transplant only macrophages, you'll get liver cells that correct liver disease in mice."

Holger Willenbring, M.D., postdoctoral fellow of molecular and medical genetics, and the study's lead author, called fusion between macrophages and hepatocytes, the cells in the liver that provide the typical functions of this organ, "a rare physiological, but potentially therapeutically exploitable, phenomenon."

"Macrophages are known to fuse with themselves," Holger said. "Therefore, it is not absolutely surprising that they can fuse with other cells as well, especially, since macrophages physiologically reside in the liver and comprise a substantial fraction of the liver cells.

Usually, they participate in resolving inflammation, taking care of debris and producing factors that help the liver to function. In addition, they provide a link between the bone marrow compartment and highly specified organ cells, and this is new and exciting because of therapeutic implications."

The findings are the latest in a series of discoveries by Grompe's laboratory since 2000, when it first showed blood-forming stem cells derived from bone marrow, called hematopoietic stem cells, can cure liver disease in mice. It later found that the liver cells were corrected by cell fusion rather than differentiation of the transplanted stem cells.

"Various labs have reported that bone marrow or blood stem cells are like super cells. They can turn into anything – liver, lung, brain, muscle," Grompe said. "Our thought was that blood stem cells are really there to repair all tissues, and we showed that you can cure liver disease with blood stem cell transplantation.

"Then we found out that the bone marrow cells were not turning into liver cells directly, but that they were fusing with preexisting liver cells instead. In cell fusion, two distinct cells meld to form a single, new cell. The liver cells were turning the blood cells into their own kind."

In the latest study, macrophages derived from bone marrow stem cells were transplanted into the spleens of mice with the genetic liver disease fumarylacetoacetate hydrolase deficiency, also called hereditary tyrosinemia in humans. Each mouse was injected with 1 million macrophages. The spleen, upstream from the liver, slowly releases the macrophages into the liver, which would otherwise wash cells away in its blood-rich environs. The result was "robust production" of functional hepatocytes..

"This means you can get away with using only macrophages in transplantation," Grompe said. "For bone marrow transplantation, to get a stem cell transplant to work, you need to treat the host with lethal doses of preparative irradiation, which has severe side effects. Here we show this harsh treatment is not necessary for macrophages to turn into useful liver cells."

Willenbring said transplantation of macrophages or their immediate, short-lived progenitors is much more targeted toward treatment of damaged liver tissue than using whole stem cells from which they're derived.

The discovery "strongly argues against stem cell plasticity because you're not using stem cells at all," Grompe said. To be sure, his laboratory used macrophages exclusively in the transplantation and "it worked." Macrophages also can more easily be grown in tissue culture than stem cells, and future studies will even look at whether they can be genetically modified before transplantation.

"That's the future. That's what we're trying to do," he said.

As for stem cell plasticity, Grompe said he and his colleagues "just don't see it," at least in liver cell repopulation.

"That could mean two things: We're blind, or it doesn't happen," he said. "I think the burden of proof is now on the people doing that work, to show that what they're seeing is not fusion."

The study was funded by the National Institutes of Health.


Story Source:

The above story is based on materials provided by Oregon Health & Science University. Note: Materials may be edited for content and length.


Cite This Page:

Oregon Health & Science University. "Macrophages, Not Stem Cells, Correct Liver Disease By Fusion." ScienceDaily. ScienceDaily, 12 July 2004. <www.sciencedaily.com/releases/2004/07/040708014035.htm>.
Oregon Health & Science University. (2004, July 12). Macrophages, Not Stem Cells, Correct Liver Disease By Fusion. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2004/07/040708014035.htm
Oregon Health & Science University. "Macrophages, Not Stem Cells, Correct Liver Disease By Fusion." ScienceDaily. www.sciencedaily.com/releases/2004/07/040708014035.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins